sorafenibRegorafenibHCChepatocellular carcinoma
…in this study (from January 2022 to January 2025), who received sorafenib treatment according to the BCLC staging system.Fifty-five patie…
3articles mentioning drugs
9drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: regorafenib ×
regorafenib
This drug is selected. Its supporting articles are shown below.
Articles mentioning regorafenib
3 articles · page 1 of 1fruquintinibregorafenibTAS-102trifluridine-tipiracilbevacizumabmCRCmetastatic colorectal cancer (mCRC)tertiary hospitals
…. The median number of prior treatment lines was four. Prior to fruquintinib, 22 patients had received TAS-102 plus bevacizumab, eight recei…
regorafenibCRCcolorectal canceranti-programmed cell death protein 1 therapy
…haustion and spatial exclusion. In preclinical models, combined regorafenib and anti-programmed cell death protein 1 therapy reduced SPP1+T…